Invest

Diabetic foot ulcers affect over 34 million Americans and cost the healthcare system $11.5 billion annually.

SenLore™ is our answer — a first-of-its-kind therapeutic device combining heat, electrical pulse stimulation, and real-time biofeedback to accelerate healing and improve patient outcomes.

We're now raising capital through an SEC-regulated equity crowdfunding campaign. Whether you're a first-time investor or a seasoned professional, you can be part of the solution.

Investing involves risk. This is not a guarantee of returns.